Covered recipient · General Payments record
KATERYNA KUZMYCHOVA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,561.49
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $497.79 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $147.94 | 4 |
| ABBVIE INC. | $103.10 | 4 |
| Neurocrine BioSciences, Inc. | $99.62 | 1 |
| Lundbeck LLC | $34.35 | 1 |
| ITI, Inc. | $27.65 | 1 |
| Otsuka America Pharmaceutical, Inc. | $26.28 | 1 |
| Supernus Pharmaceuticals, Inc. | $22.02 | 1 |
| Tris Pharma Inc | $21.69 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.88 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494736 | CMS |
| ABBVIE INC. | $22.07 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494738 | CMS |
| ABBVIE INC. | $14.02 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494740 | CMS |
| ABBVIE INC. | $32.13 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494742 | CMS |
| Alkermes, Inc. | $85.19 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120537347 | CMS |
| Alkermes, Inc. | $18.62 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120537349 | CMS |
| Alkermes, Inc. | $12.28 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120537351 | CMS |
| Alkermes, Inc. | $31.85 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120537353 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101764954 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27.65 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143529722 | CMS |
| Lundbeck LLC | $34.35 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146048558 | CMS |
| Neurocrine Biosciences, Inc. | $99.62 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150925597 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.28 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119117057 | CMS |
| Supernus Pharmaceuticals, Inc. | $22.02 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147850491 | CMS |
| Tris Pharma Inc | $21.69 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147205285 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.